The latest news for pharma industry insiders.
You Are Forgetting the Patient, but You’re Not Alone
Vincent Keunen, founder and CEO of Andaman7 shares his thoughts on how industry can achieve true patient centricity through emerging platforms and digital tools.
By functioning as an antibody replacement therapy, IVIG can be used to manage a wide range of inflammatory and autoimmune disorders.
Big Pharma Rallies and Moves Past Obesity
Rotation into laggard pharmaceutical stocks is being helped by optimism over regulations.
Advanced Clinical Announces Opening of New Office in India
Advanced Clinical announced the opening of a new office in Ahmedabad, India. This strategic expansion marks a significant milestone in its ongoing global expansion efforts and underscores a commitment to addressing the evolving needs of the company’s clients while becoming more competitive in the global market.
Miranda Schmalfuhs on LinkedIn
Check out the first part of my insightful talk with Charlotte Owens, MD, FACOG of Organon and keep your eyes on Pharmaceutical Executive for the other parts of our talk posting every morning this week!
Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
Unlocking value and cost savings in patient services with technology and talent
October 2nd 2024Traci Miller, Director, Sonexus™ Access and Patient Support, Cardinal Health, discusses the current digital trends in the patient services industry and how the optimal balance of technology and talent can transform manufacturer-sponsored patient support programs. Hear how Cardinal Health combines best-in-class program and pharmacy operations with smart digital tools to ensure product and patient success and reduce operational costs.
FDA Grants Priority Review to GSK’s Gepotidacin for Uncomplicated Urinary Tract Infections
October 18th 2024Priority Review status for GSK’s New Drug Application for gepotidacin was based on promising results from the Phase III EAGLE-2 and EAGLE-3 trials, which demonstrated non-inferiority to nitrofurantoin in uncomplicated urinary tract infections.